Celldex Therapeutics, Inc. - Common Stock, par value $0.001 per share (CLDX)

CUSIP: 15117B202

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
67,629,115
Total 13F shares
69,311,318
Share change
+8,395,409
Total reported value
$2,908,781,828
Put/Call ratio
141%
Price per share
$41.97
Number of holders
196
Value change
+$362,625,073
Number of buys
125
Number of sells
53

Quarterly Holders Quick Answers

What is CUSIP 15117B202?
CUSIP 15117B202 identifies CLDX - Celldex Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Celldex Therapeutics, Inc. - Common Stock, par value $0.001 per share (CLDX) as of Q1 2024

As of 31 Mar 2024, Celldex Therapeutics, Inc. - Common Stock, par value $0.001 per share (CLDX) was held by 196 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 69,311,318 shares. The largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, EVENTIDE ASSET MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, Polar Capital Holdings Plc, STATE STREET CORP, Kynam Capital Management, LP, and Bellevue Group AG. This page lists 196 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.